EDGAR Filing Documents for 0001104659-21-055818

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001104659-21-055818

Filing Date

2021-04-28

Accepted

2021-04-27 20:08:08

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POS AM	tm2114229d1_posam.htm	POS AM	572380
2	EXHIBIT 23.1	tm2114229d1_ex23-1.htm	EX-23.1	3956
	Complete submission text file	0001104659-21-055818.txt		577505

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: POS AM | Act: 33 | File No.: 333-227752 | Film No.: 21860981
SIC: 2834 Pharmaceutical Preparations